Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Becatecarin

Generic Name: Becatecarin

Drug Type: Small Molecule

Chemical Formula: C_₃₃H_₃₄Cl_₂N_₄O_₇

CAS Number: 119673-08-4

Unique Ingredient Identifier: A60X6MBU6G

Overview

Becatecarin is a derivative of rebeccamycin.

Background

Becatecarin is a derivative of rebeccamycin.

Indication

Investigated for use/treatment in cancer/tumors (unspecified), liver cancer, gastric cancer, and leukemia (unspecified).

Associated Conditions

No associated conditions information available.

Clinical Trials

XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors

Phase 3

Terminated

Posted: 2004/08/23

Sponsor:Helsinn Healthcare S...

ID:NCT00090025

Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia

Phase 1

Completed

Posted: 2004/07/12

Sponsor:National Cancer Inst...

ID:NCT00087204

Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid Tumors

Phase 1

Terminated

Posted: 2004/07/12

Sponsor:National Cancer Inst...

ID:NCT00086983

Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy

Phase 2

Terminated

Posted: 2004/06/11

Sponsor:National Cancer Inst...

ID:NCT00084487

Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer

Phase 2

Terminated

Posted: 2004/03/25

Sponsor:Northwestern Univers...

ID:NCT00006262

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy